CheckMyRecalls

Cipla USA, Inc. recalls Diclofenac Sodium Topical Gel

Published
28 Jan 2026
Units affected
92,376 tubes
Agency
FDA
Country
United States

The hazard

Failed PH Specifications

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio, TX 78215. NDC: 76282-103-39

Brand / company
Cipla USA, Inc.
Codes / lots
Batch XHBG; Exp. 08/31/2027
Distribution
Nationwide in the USA
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 28 Jan 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.